AI Analysis AI Analysis of PTPI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PTPI to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Petros Pharmaceuticals Inc stock price down 0% on Friday
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 19, 2026 Loss -9.84%

No changes to the price of Petros Pharmaceuticals Inc stock on the last trading day (Friday, 5th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0055 to a day high of $0.0055. The price has been going up and down for this period, and there has been a -9.84% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.31% during the next 3 months and, with a 90% probability hold a price between $0.0039 and $0.0065 at the end of this 3-month period.

PTPI Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 10.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Petros Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0056 and $0.0064. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Petros Pharmaceuticals Inc stock

Petros Pharmaceuticals Inc finds support from accumulated volume at $0.0053 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 17.75%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PTPI) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Petros Pharmaceuticals Inc to open at $0.0055, and during the day (based on 14 day Average True Range), to move between $0.0051 and $0.0059, which gives a possible trading interval of +/-$0.0007 (+/-14.31%) up or down from last closing price. If Petros Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 14.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0053 (3.64%) than the resistance at $0.0061 (10.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Petros Pharmaceuticals Inc stock A Buy?

Petros Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.347 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.0055 ( 0.00000000000002%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PTPI Performance

Trading levels for PTPI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0055 0.00000000000002%
R2 0.0055 0.00000000000002%
R1 0.0055 0.00000000000002%
Price 0.0055
S1 0.0055 0.00000000000002%
S2 0.0055 0.00000000000002%
S3 0.0055 0.00000000000002%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0065 18.18%
R2 0.0062 12.73%
R1 0.0061 10.91%
Price 0.0055
S1 0.0053 -3.64%
S2 0.0052 -5.45%
S3 0.0050 -9.09%

FAQ

What is the symbol for Petros Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Petros Pharmaceuticals Inc is PTPI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Petros Pharmaceuticals Inc Stock?
Petros Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Petros Pharmaceuticals Inc Stock?
Petros Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Petros Pharmaceuticals Inc Stock.

What's the current price of Petros Pharmaceuticals Inc Stock?
As of the end of day on the Jun 05, 2026, the price of an Petros Pharmaceuticals Inc (PTPI) share was $0.0055.

What is the 52-week high and low for Petros Pharmaceuticals Inc Stock?
The 52-week high for Petros Pharmaceuticals Inc Stock is $0.0400 and the 52-week low is $0.0050.

What is the market capitalization of Petros Pharmaceuticals Inc Stock?
As of the Jun 05, 2026, the market capitalization of Petros Pharmaceuticals Inc is 171.381K.
Click to get the best stock tips daily for free!
ABOUT PETROS PHARMACEUTICALS INC
Petros Pharmaceuticals
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vac...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE